Daiichi Sankyo To Transfer Yescarta Marketing Authorization In Japan To Gilead Sciences

Daiichi Sankyo To Transfer Yescarta Marketing Authorization In Japan To Gilead Sciences

Source: 
NASDAQ.com
snippet: 

Daiichi Sankyo Co., Ltd. (DSKYF.PK) will transfer yescarta marketing authorization in Japan to Gilead Sciences K.K., the Japan subsidiary of Gilead Sciences Inc. (GILD), in 2023, the companies said in a statement.